Journal Report

Journal of the Neurological Sciences

Download PDF
Journal Information
Journal Title
Journal of the Neurological Sciences
Publisher
ISSN
0022-510X
E-ISSN
Database
AERES
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
A potential biomarker for the efficacy of complement inhibitors in myasthenia gravis
Etsuko Ogaya, Akiyuki Uzawa, Hiroyuki Akamine et al.
2026-12 Vol. 491 Pages 126212
DOI: 10.1016/j.jns.2026.126212
Paradoxical ethnic differences in prevalence of vascular risk factors versus extracranial atherosclerotic disease in TIA/stroke patients in the United Kingdom: Population-based study and meta-analysis
Joseph Kamtchum-Tatuene, Linxin Li, Peter M. Rothwell
2026-12 Vol. 491 Pages 126238
DOI: 10.1016/j.jns.2026.126238
The prognostic role of echocardiographic parameters in ischemic stroke patients with atrial fibrillation
Annaelle Zietz, Alexandros A. Polymeris, Beat A. Kaufmann et al.
2026-12 Vol. 491 Pages 126234
DOI: 10.1016/j.jns.2026.126234
Comment on “Lower atrial fibrillation detection in cryptogenic stroke patients with patent foramen ovale: Evidence from insertable cardiac monitoring”
Haijun Chen, Mengying Hu
2026-12 Vol. 491 Pages 126189
DOI: 10.1016/j.jns.2026.126189
Prolonged Guillain-Barre´ Syndrome: longstanding demyelination and axonopathy
Francis Gerwin Jalipa, Peter Dobrowolski, Sameer Chhibber et al.
2026-12 Vol. 491 Pages 126233
DOI: 10.1016/j.jns.2026.126233
Baló's concentric sclerosis: Longitudinal analysis of 20 patients revealing a clinical phenotype distinct from multiple sclerosis
Regina M.P. Alvarenga, Débora C de Souza de Oliveira, Marina P. Alvarenga et al.
2026-12 Vol. 491 Pages 126227
DOI: 10.1016/j.jns.2026.126227
Antithrombotic use patterns for secondary stroke prevention in ischemic stroke patients with active malignancy: The STOP-SPAM study
Dylan Ryan, Tracy Truong, Michael W. Lutz et al.
2026-12 Vol. 491 Pages 126173
DOI: 10.1016/j.jns.2026.126173
Glucagon-like peptide-1 as a recovery biomarker after traumatic brain injury in patients with obesity: Preliminary results
Shawn R. Eagle, Mahesh K. Basantani, Ava Puccio et al.
2026-12 Vol. 491 Pages 126232
DOI: 10.1016/j.jns.2026.126232
Drug-coated balloon versus stent angioplasty in patients with intracranial atherosclerotic stenosis: A systematic review and meta-analysis
Aya Magdy Siam, Omar Fayez Abbas, Nour Aldin T. Ahmed et al.
2026-12 Vol. 491 Pages 126214
DOI: 10.1016/j.jns.2026.126214
Long-term outcomes of alemtuzumab in relapsing–remitting multiple sclerosis: a real-world cohort with particular focus on treatment sequencing after natalizumab
Marta Gaggiola, Valentina Annamaria Mauceri, Giovanni Zanotelli et al.
2026-12 Vol. 491 Pages 126210
DOI: 10.1016/j.jns.2026.126210
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 9, 2026 07:30